Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Dificid Hits Sales Goal under Cubist Collaboration
Go back to Needham & Company Reiterates a 'Buy' on Optimer Pharmaceuticals (OPTR); Dificid Hits Sales Goal under Cubist Collaboration| Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) | Delayed: 101.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $101.94 | 52 Week High | $101.99 | |||
| Open | $3.23 | 52 Week Low | $58.50 | |||
| Day High | $101.94 | P/E | N/A | |||
| Day Low | $101.94 | EPS | $-0.27 | |||
| Volume | 3,714 | |||||
| Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) | Delayed: 12.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.78 | 52 Week High | $16.80 | |||
| Open | $12.78 | 52 Week Low | $8.64 | |||
| Day High | $12.78 | P/E | N/A | |||
| Day Low | $12.78 | EPS | $-1.75 | |||
| Volume | 1,179,540 | |||||
